MIHARI project, a preceding study of MID-NET, adverse event detection database of Ministry Health of Japan-Validation study of the signal detection of adverse events of drugs using export data from EMR and medical claim data.
We studied the effectiveness of the direct data collection from electronic medical records (EMR) when it is used for monitoring adverse drug events and also detection of already known adverse events. In this study, medical claim data and SS-MIX2 standardized storage data were used to identify four d...
Enregistré dans:
Auteurs principaux: | Hiroshi Watanabe, Kiyoteru Takenouchi, Michio Kimura |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8d2e6be4694942dcb60b5a1ed61be1d6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Drug-use patterns and severe adverse events with disease-modifying drugs in patients with multiple sclerosis: a cohort study based on German claims data
par: Simbrich A, et autres
Publié: (2019) -
Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
par: Han N, et autres
Publié: (2021) -
A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data
par: Bin Wu, et autres
Publié: (2021) -
Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity
par: Majid Jaberi-Douraki, et autres
Publié: (2021) -
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe.
par: Emanuel Raschi, et autres
Publié: (2013)